Venkatraman, Deepti
Dana-Farber Cancer Institute
3 papers on CoChatORCID 0009-0002-5068-4706
Most cited papers
- Verified
Diminished efficacy of programmed death-(ligand)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status
Ricciuti, B., Arbour, K. C., Lin, J. J., Vajdi, A., Vokes, N., Hong, L., Zhang, J., Tolstorukov, M. Y., Li, Y. Y., Spurr, L. F., et al. (2022) · Journal of Thoracic Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 394
- Verified
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Skoulidis, F., Araujo, H. A., Do, M. T., Qian, Y., Sun, X., Galan-Cobo, A., Le, J. T., Montesion, M., Palmer, R., Jahchan, N., et al. (2024) · Nature
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 194
- Verified
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC
Alessi, J. V., Elkrief, A., Ricciuti, B., Wang, X., Cortellini, A., Vaz, V. R., Lamberti, G., Frias, R. L., Venkatraman, D., Fulgenzi, C. A. M., et al. (2023) · Journal of Thoracic Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 97
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free